HOPE STODDART: Open Payments
NPI 1861757858 · WEST CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,250 in 33 payments from 17 companies in 2025. Trend: 2023 $692 · 2024 $882 · 2025 $1,250
Food & beverage: $1,150Education: $100
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $319 |
| Madrigal Pharmaceuticals | 1 | $150 |
| Daiichi Sankyo Inc. | 2 | $128 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| Genentech USA, Inc. | 3 | $76 |
| GENZYME CORPORATION | 2 | $57 |
| Merck Sharp & Dohme LLC | 3 | $52 |
| Janssen Biotech, Inc. | 2 | $46 |
| TAIHO ONCOLOGY, INC. | 2 | $37 |
Products named: MONJUVI, REZDIFFRA, Enhertu, REBLOZYL, NIKTIMVO, SARCLISA, Phesgo, Venclexta.
Industry payments across PA — which companies pay providers there.
